| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Drug Development | Executive VP, Drug Development
2 companies
Manhard Kimberly serves as an EVP, Drug Development at HRTX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 20 sells. Those positions are worth an estimated $788K at current prices.
Historically, Manhard Kimberly's trades have earned a strong insider score of 80/100 across 3 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +74.4%.
The biggest single holding is INBX (~$788K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 7,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2018 | HRTX Heron Therapeutics, Inc. /de/ | Executive VP, Drug Development | Sale+OE | 6,000 | $32.07 | $192,433.20 | -100% | |
| Jul 2, 2018 | HRTX Heron Therapeutics, Inc. /de/ | Executive VP, Drug Development | Sale+OE | 6,000 | $37.53 | $225,178.66 | -100% | |
| Mar 19, 2018 | HRTX Heron Therapeutics, Inc. /de/ | Executive VP, Drug Development | Sale+OE | 18,000 | $30.00 | $540,000.00 | -100% | |
| Jan 10, 2018 | HRTX Heron Therapeutics, Inc. /de/ | Executive VP, Drug Development | Sale+OE | 7,584 | $20.00 | $151,680.00 | -100% | |
| Apr 24, 2017 | HRTX Heron Therapeutics, Inc. /de/ | Executive VP, Drug Development | Sale+OE | 21,542 | $15.33 | $330,262.56 | -100% | |
| Jun 2, 2015 | HRTX Heron Therapeutics, Inc. /de/ | Director | Sale+OE | 13,208 | $23.09 | $304,918.36 | -100% |